Space for Electromobility
14/08/2024
Crafting a Standout Innovation Grant Application: 10 Vital Elements
27/08/2024
Up to £100k
Project Value
3- 6 months
Project Length
16th October 2024
Competition Closes
This competition aims to provide seed funding to establish a consortium and prepare a case for a later, fully sustainable medicine manufacturing-themed Grand Challenge award.
A Grand Challenge is a large-scale collaborative research and development (CR&D) award, up to £10 million, involving at least three partners across the medicines manufacturing supply chain.
This is phase 1 of a 2-phase competition:
- Phase 1: expressions of interest (EoI) phase (this competition)
- Phase 2: full Grand Challenge phase
Fund details
Expression of Interest (EoI)
Funding for this EoI phase must be used to support the collaborative development of your application for the Grand Challenge phase.
This includes:
- building a consortium
- convening discussions
- hosting workshops
- engaging communities
- collaborative bid writing
- desk research
- coordination of the consortium
- developing mechanisms to gather impact and benefits data which will be required at the Grand Challenge phase
Consortia awarded funding at the EoI phase will be invited to apply for the Grand Challenge phase competition, which will open in, or after, June 2025. Further details about the application timeline and requirements for this phase will be released in due course.
Grand Challenge Phase
In the Grand Challenge phase, Innovate UK aims to support organisations that have the potential to innovate and develop technologies for sustainable medicine manufacturing.
Your project must address at least one of these three key pillars:
- green chemistry
- circularity
- productivity and resource
Your project must also address both critical enablers:
- regulations
- measurements, standards and data